Back to
Bank of New York Mellon Corp
AXSMShowing 8 of 28 quarters
Position history for
Bank of New York Mellon Corp's holdings in AXSOME THERAPEUTICS INC.
Yes. Bank of New York Mellon holds 197,226 shares of AXSM (Axsome Therapeutics), worth $48.3M, as of its Q2 2026 13F filing. It reduced the position by 9,418 shares (-4.6%) from Q1 2026. Bank of New York Mellon has held AXSM in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$48.3M
Current Shares
197,226
Total Value Change
+$36M
Total Shares Change
+60,780
Quarter-by-Quarter History
Other major holders of AXSM: VANGUARD GROUP INC, BlackRock, Inc.